Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CONCERT-PHARMACEUTICALS-I-15789602/news/Concert-Pharmaceuticals-gibt-die-Prasentation-der-Ergebnisse-der-Phase-3-Studie-Deuruxolitinib-Thri-42383565/?utm_source=whatsapp&utm_medium=social&utm_campaign=share